Medication info
Fosquin 70 mg Tablet (Sodium Alendronate)

Fosquin 70 mg Tablet (Sodium Alendronate)

Prescription medicationTabletOral
Ingredient · strength
Sodium Alendronate›91.37mg / 1 tablet
Manufacturer / importer
(Co., Ltd.) Jungkundang
Appearance
White oval tablet
Packaging
4 tablets/box (4 tablets/PTP x 1)
Approval status
Active

MFDS item code 200500125 · Approved 2005.01.12 · Insurance code 643304010

Summary

Main use
Treatment of osteoporosis in postmenopausal women and men
Who takes it
Adults
Adult dose
○ Take alendronic acid 70 mg once weekly in the morning with plenty of water, at least 30 minutes before consuming food, beverages, or other medicines (see Precautions). ○ Other beverages or foods, including mineral water and barley tea, and medicines may reduce the absorption of this drug (see Interactions). Consuming food within 30 minutes after taking this drug, or at the same time, may reduce its absorption into the body and diminish its effect. Take this drug as soon as you get up in the morning and swallow it with plenty of water (170 ∼ 230 mL) to ensure rapid delivery to the stomach and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking it and until after your first food intake. Do not take this drug at bedtime or before getting up for the day. Failure to follow these instructions may increase the risk of esophageal adverse reactions (see Warnings and Precautions). Patients with insufficient calcium and vitamin D intake from food should take supplements (see Precautions). ○ The optimal duration of treatment has not been established. The safety and efficacy of this drug for the treatment of osteoporosis are based on 4 years of clinical data. The need for continued treatment should be reassessed regularly in all patients receiving bisphosphonates. In patients at low risk of fracture, discontinuation should be considered after 3 ∼ 5 years of treatment. Patients who discontinue treatment should be reassessed regularly for fracture risk. ○ If you forget to take a dose on the scheduled day, take 70 mg the next morning, resume taking it on the originally scheduled day, and then continue taking it regularly once weekly. Do not take 2 tablets on the same day.

Ingredients

Manufacturer
(Co., Ltd.) Jungkundang

Efficacy & effects

Treatment of osteoporosis in postmenopausal women and men

  • Osteoporosis
View approved original text

Used for the treatment of osteoporosis in postmenopausal women and men.

How to take

Adult dose

○ Take alendronic acid 70 mg once weekly in the morning with plenty of water, at least 30 minutes before consuming food, beverages, or other medicines (see Precautions). ○ Other beverages or foods, including mineral water and barley tea, and medicines may reduce the absorption of this drug (see Interactions). Consuming food within 30 minutes after taking this drug, or at the same time, may reduce its absorption into the body and diminish its effect. Take this drug as soon as you get up in the morning and swallow it with plenty of water (170 ∼ 230 mL) to ensure rapid delivery to the stomach and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking it and until after your first food intake. Do not take this drug at bedtime or before getting up for the day. Failure to follow these instructions may increase the risk of esophageal adverse reactions (see Warnings and Precautions). Patients with insufficient calcium and vitamin D intake from food should take supplements (see Precautions). ○ The optimal duration of treatment has not been established. The safety and efficacy of this drug for the treatment of osteoporosis are based on 4 years of clinical data. The need for continued treatment should be reassessed regularly in all patients receiving bisphosphonates. In patients at low risk of fracture, discontinuation should be considered after 3 ∼ 5 years of treatment. Patients who discontinue treatment should be reassessed regularly for fracture risk. ○ If you forget to take a dose on the scheduled day, take 70 mg the next morning, resume taking it on the originally scheduled day, and then continue taking it regularly once weekly. Do not take 2 tablets on the same day.

Precautions

This medication can irritate the mucous membranes of the stomach and esophagus, so patients with upper gastrointestinal diseases should be particularly cautious. Take this drug with a sufficient amount of water and do not lie down for at least 30 minutes after taking it. If any abnormal symptoms in the esophagus appear, discontinue taking the medication immediately and consult a doctor. Patients with esophageal discharge disorders such as esophageal stricture or achalasia, patients who cannot sit or stand upright for more than 30 minutes, and patients allergic to this drug's components should not take this medication. Patients with hypocalcemia, severe renal failure, or pregnant or breastfeeding women should also refrain from using this drug. During treatment, it is important to ensure adequate calcium and vitamin D intake, maintain weight-bearing exercises, and uphold a healthy lifestyle. This medication may cause side effects such as abdominal pain, indigestion, nausea, and constipation, and in rare cases, serious side effects such as esophagitis or esophageal ulcers may occur. Musculoskeletal pain or skin rashes may arise during treatment, so if symptoms are severe, consult healthcare professionals. Long-term use may increase the risk of low-energy bone fractures, so regular testing is necessary. When taking this medication with other drugs, absorption may be hindered, so calcium supplements or antacids should be taken at least 30 minutes after this medication. It is safest for pregnant or breastfeeding women not to take this drug, and safety in children or adolescents under 18 has not been established. Elderly patients can use it, but some may react more sensitively, so caution is needed. In case of overdose, gastrointestinal irritation symptoms may appear, so inform healthcare professionals immediately, and do not induce vomiting. This medication should be kept out of reach of children, and transferring it to another container should be avoided.

Side effects

Esophagitis, esophageal ulcer, esophageal erosion, esophageal obstruction, esophageal perforation, bleeding, gastric ulcer, duodenal ulcer, abdominal pain, nausea, dyspepsia, constipation, diarrhea, flatulence, acid reflux, vomiting, dysphagia, abdominal distension, gastritis, musculoskeletal pain, muscle cramps, headache, dizziness, taste disturbance, rash, erythema, anastomotic ulcer, symptoms of hypocalcemia, peripheral edema, oropharyngeal ulcer, osteomyelitis, jaw necrosis, joint edema, low-energy fractures of the femoral neck and other bones, dizziness, itching, hair loss, mucocutaneous syndrome, toxic epidermal necrolysis, uveitis, scleritis, episcleritis, cholesteatoma of the external auditory canal, melena

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it should be stored in a tightly closed container. Additionally, it is best kept in a cool place between 15 and 30 degrees Celsius. Proper storage maintains the drug's effectiveness.

Appearance and packaging

Appearance

White oval tablet

Package unit

4 tablets/box (4 tablets/PTP x 1)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.